Bessemer Group Inc. lifted its position in shares of Danaher Corporation (NYSE:DHR) by 14.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,498,892 shares of the conglomerate’s stock after buying an additional 450,997 shares during the quarter. Danaher Corporation comprises about 1.2% of Bessemer Group Inc.’s holdings, making the stock its 11th largest position. Bessemer Group Inc. owned 0.50% of Danaher Corporation worth $300,135,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. GQG Partners LLC bought a new position in Danaher Corporation during the second quarter worth $101,000. Proficio Capital Partners LLC boosted its stake in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares in the last quarter. Monetary Management Group Inc. boosted its stake in Danaher Corporation by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares in the last quarter. Acrospire Investment Management LLC boosted its stake in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares in the last quarter. Finally, Motco boosted its stake in Danaher Corporation by 8.8% during the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after acquiring an additional 163 shares in the last quarter. Institutional investors own 75.56% of the company’s stock.

In related news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the transaction, the director now owns 104,621 shares in the company, valued at approximately $9,501,679.22. The disclosure for this sale can be found here. Insiders have sold a total of 317,498 shares of company stock valued at $28,838,801 in the last quarter. Insiders own 12.20% of the company’s stock.

A number of research analysts have weighed in on the stock. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Cowen and Company reaffirmed a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday, October 4th. Jefferies Group LLC restated a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a report on Friday, August 4th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a $83.00 price target on shares of Danaher Corporation in a research note on Tuesday, September 26th. Finally, Robert W. Baird upped their price target on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $93.31.

Danaher Corporation (DHR) opened at $94.18 on Wednesday. The company has a market capitalization of $65,164.29, a PE ratio of 24.08, a price-to-earnings-growth ratio of 2.23 and a beta of 1.02. Danaher Corporation has a one year low of $76.27 and a one year high of $94.22. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 earnings per share. sell-side analysts expect that Danaher Corporation will post 3.99 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.59%. Danaher Corporation’s dividend payout ratio (DPR) is 16.52%.

TRADEMARK VIOLATION NOTICE: “Danaher Corporation (DHR) Stake Raised by Bessemer Group Inc.” was reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/11/22/danaher-corporation-dhr-stake-raised-by-bessemer-group-inc.html.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.